LILRB3 has been shown to be induced by IFNy, polyIC, and cytarabine in AML cell lines and patient samples [21], while hypomethylating agents and fat mass and obesity-associated protein (FTO) induced LILRB4 expression in AML cells [19, 24]. Here, LILRB3 is linked to acute myeloid leukemia.